Invesco S&P SmallCap Health Care ETF financials
$56.96−1.39%
Close Nov 12, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q3 '26 Sep 30 | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.87B | $1.83B | $1.74B | $1.69B | $1.64B | $1.52B | $1.53B | $1.59B | $1.52B | $1.48B | $1.48B | $1.41B |
| Gross profit | $1.87B | $1.83B | $1.74B | $1.69B | $1.64B | $1.52B | $1.53B | $1.59B | $1.52B | $1.48B | $1.48B | $1.41B |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | $436.5M | $364.2M | $333.2M | -$1.46B | $270.9M | $214.2M | $277.3M | $311.7M | $100.5M | $206.8M | $213.1M | -$1.08B |
| Net income | $294.5M | $345.3M | $230.4M | -$1.19B | $301.3M | -$12.5M | $171.1M | $209.3M | $55.0M | $132.2M | $141.5M | -$742.3M |
| Net margin | 15.7% | 18.9% | 13.2% | −70.1% | 18.4% | −0.8% | 11.2% | 13.1% | 3.6% | 8.9% | 9.6% | −52.5% |
| Diluted EPS | $0.65 | $0.76 | $0.51 | $-2.60 | $0.66 | $-0.03 | $0.38 | $0.45 | $0.12 | $0.29 | $0.31 | $-1.64 |
| EBITDA | $468.1M | $396.4M | $366.4M | -$1.42B | $309.2M | $254.3M | $318.8M | $355.8M | $144.5M | $253.2M | $258.2M | -$1.08B |
| Operating cash flow | $475.0M | $821.6M | $125.2M | $455.8M | $606.2M | $689.2M | -$225.9M | $316.9M | $438.4M | $502.5M | -$67.8M | $353.8M |
| Free cash flow | $442.8M | $791.1M | $111.0M | $432.2M | $586.4M | $671.7M | -$249.3M | $309.9M | $410.0M | $475.8M | -$88.8M | $313.5M |
| Diluted shares | 452.5M | 454.4M | 453.7M | 456.2M | 454.6M | 455.2M | 454.0M | 465.6M | 455.6M | 456.1M | 453.5M | 454.0M |
Balance sheet
| Period end | Sep 30 | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $965.5M | $915.4M | $806.9M | $1.04B | $973.1M | $922.7M |
| Short-term investments | $0.00 | $1.45B | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.28B | $1.62B | $1.97B | $1.83B | $1.62B | $1.88B |
| Total assets | $27.65B | $27.47B | $26.83B | $27.09B | $28.44B | $28.50B |
| Total liabilities | $14.02B | $14.00B | $13.57B | $14.09B | $13.65B | $13.54B |
| Shareholders' equity | $13.63B | $13.11B | $12.94B | $13.00B | $14.64B | $14.43B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology